Schedule 13G ownership disclosure

ImmunoCellular Therapeutics, Ltd.

Security class unavailable · CUSIP: 452536105

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,664,397
Percent of class
4.0600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-16-000110
Form type
SC 13G/A
Filer
ImmunoCellular Therapeutics, Ltd.
CIK
CIK 822411
Filed
Jan 12, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub